Melanoma skin change - Causes, Treatment & When to See a Doctor

```html

What is Melanoma skin change?

Melanoma is a malignant tumor that arises from melanocytes – the pigment‑producing cells found in the skin, eyes, mucous membranes and, rarely, other organs. A “melanoma skin change” refers to any alteration in the appearance of a mole or pigmented patch that raises suspicion for this aggressive form of skin cancer.

Unlike most non‑cancerous moles, melanomas can evolve quickly, develop new colors, or spread beyond the skin. Early detection dramatically improves survival; the 5‑year survival rate exceeds 99 % when the tumor is caught while still in situ (stage 0) but drops sharply once it has metastasized.

Sources: Mayo Clinic; CDC.

Common Causes

While the word “cause” is a bit of a misnomer—melanoma results from DNA damage rather than an acute condition—several risk factors and underlying conditions increase the likelihood of a melanoma‑type skin change.

• Ultraviolet (UV) radiation exposure – Cumulative sun exposure and intermittent intense sunburns are the most important modifiable risk factor.
• Fair skin, red or blond hair, and light eyes – Less melanin means less natural protection against UV damage.
• Family history of melanoma – Genetic predisposition accounts for ~10 % of cases.
• Personal history of melanoma or other skin cancers – Prior disease raises the risk of recurrence.
• Presence of many dysplastic (atypical) nevi – These irregular moles have higher malignant potential.
• Immunosuppression – Transplant recipients, HIV infection, or chronic corticosteroid use reduce immune surveillance.
• Certain genetic mutations – CDKN2A, BRAF, NRAS, and MC1R variants are linked to higher risk.
• Excessive indoor tanning – UV‑emitting tanning beds deliver a concentrated dose of UV‑A and UV‑B radiation.
• Geographic location – Living at high altitudes or near the equator increases UV intensity.
• Chronic inflammation or scar tissue – Rarely, melanoma can arise in long‑standing scars (Marjolin ulcer).

Associated Symptoms

Melanoma may be the only visible change, but many patients notice additional signs that suggest the lesion is evolving.

• Asymmetry – one half of the mole looks different from the other.
• Border irregularities – edges are scalloped, notched, or blurred.
• Color variation – shades of black, brown, gray, red, blue, or white appear together.
• Diameter >6 mm (about the size of a pencil eraser) – though some melanomas are smaller.
• Evolving shape, size, or color over weeks to months.
• Itching, tenderness, or pain in the area.
• Bleeding, oozing, or crusting without obvious injury.
• Elevation or growth of a raised nodule on or adjacent to the lesion.

These features compose the widely used “ABCDE” rule for melanoma detection (Asymmetry, Border, Color, Diameter, Evolution).

When to See a Doctor

Any new or changing pigmented spot should be evaluated promptly, especially if one or more of the following are present:

• Rapid increase in size or height.
• Irregular or ragged borders.
• Multiple colors or an unusual hue (e.g., blue or black).
• Bleeding, ulceration, or crust formation.
• Persistent itching, pain, or soreness.
• History of melanoma, a large number of atypical moles, or strong family history.

If you notice any of these changes, schedule an appointment with a dermatologist or your primary care provider within days—not weeks.

Diagnosis

Evaluation follows a stepwise approach to confirm whether a lesion is benign or malignant.

1. Clinical skin exam

The clinician uses a dermatoscope—a magnifying, light‑enhanced instrument—to inspect the lesion’s pattern. The “ABCDE” criteria, the “Ugly Duckling” sign (a mole that looks different from the patient’s other moles), and the “7‑point checklist” may be applied.

2. Skin biopsy

If the lesion looks suspicious, a tissue sample is taken. The most common methods are:

• Excisional biopsy – removal of the entire mole with a narrow margin of normal skin; preferred for lesions < 2 cm.
• Punch biopsy – a circular core of tissue, used when the lesion is large or in a difficult location.
• Incisional (or shave) biopsy – sampling a portion of a thicker lesion; less ideal because it may miss deeper invasion.

The specimen is examined by a dermatopathologist for histologic features (e.g., depth of invasion measured as Breslow thickness, ulceration, mitotic rate).

3. Staging tests (if melanoma is confirmed)

When a melanoma is diagnosed, further work‑up determines if it has spread:

• Sentinel lymph node biopsy – identifies microscopic spread to regional nodes.
• Imaging – ultrasound, CT, PET/CT, or MRI based on stage and symptoms.
• Blood tests – lactate dehydrogenase (LDH) may be elevated in advanced disease.

4. Genetic testing (optional)

Targeted therapy decisions often rely on identifying mutations (BRAF V600E/K, NRAS, KIT). Some labs also test for germline CDKN2A mutations in families with multiple melanomas.

Treatment Options

Treatment is driven by tumor thickness, ulceration, location, and whether it has metastasized. The goals are complete removal, prevention of recurrence, and preservation of function/cosmesis.

Surgical Management

• Wide local excision – removal of the melanoma with a safety margin of normal skin (0.5–2 cm depending on Breslow depth). This is the cornerstone for stages 0‑II.
• Sentinel lymph node dissection – performed if the sentinel node is positive.
• Reconstruction – skin grafts or local flaps may be needed for large defects, especially on the face or extremities.

Adjuvant Therapies (post‑surgery)

• Immunotherapy – checkpoint inhibitors (nivolumab, pembrolizumab, ipilimumab) improve recurrence‑free survival for high‑risk stage III‑IV disease.
• Targeted therapy – BRAF inhibitors (vemurafenib, dabrafenib) combined with MEK inhibitors (trametinib, cobimetinib) for BRAF‑mutated melanomas.
• Interferon‑α – historically used but now largely replaced by newer agents due to toxicity.

Systemic Therapy for Advanced Disease

• Immune checkpoint blockade (PD‑1 inhibitors).
• Combination BRAF/MEK inhibition.
• Oncolytic virus therapy (talimogene laherparepvec – T‑VEC) for injectable skin lesions.
• Clinical trials – many novel agents are under investigation.

Home and Supportive Care

• Wound care – keep surgical sites clean, apply prescribed ointments, and monitor for infection.
• Sun protection – daily broad‑spectrum sunscreen (SPF 30 +), protective clothing, and avoiding peak UV hours.
• Skin self‑checks – monthly examination of the whole body; enlist a partner for hard‑to‑see areas.
• Psychological support – counseling, support groups, or survivorship programs are valuable, as melanoma diagnosis can cause anxiety.

Prevention Tips

Because UV exposure is the primary modifiable risk, a layered approach works best.

• Apply sunscreen with at least SPF 30, broad spectrum, water‑resistant; reapply every 2 hours or after swimming/sweating.
• Seek shade between 10 a.m. and 4 p.m. when UV rays are strongest.
• Wear protective clothing – long‑sleeve shirts, wide‑brim hats, and UV‑blocking sunglasses.
• Avoid indoor tanning – tanning beds increase melanoma risk by up to 59 % in young adults.
• Perform regular skin exams – self‑examination and professional skin checks at least once a year.
• Know your risk profile – discuss family history, number of moles, and any genetic concerns with a dermatologist.
• Stay hydrated and maintain a healthy diet – antioxidants from fruits and vegetables may provide marginal protection, though they do not replace UV avoidance.

Emergency Warning Signs

Key Take‑aways

Melanoma skin change is a potentially life‑threatening alteration in a pigmented lesion. Early recognition, prompt dermatologic evaluation, and appropriate treatment dramatically improve outcomes. Protecting yourself from UV radiation, performing regular self‑exams, and seeking medical attention at the first sign of change remain the most effective strategies.

For detailed, personalized advice, always consult a board‑certified dermatologist or oncologist.

References:

1. Mayo Clinic. Melanoma – Symptoms and causes. Accessed May 2026.
2. Centers for Disease Control and Prevention. Melanoma skin cancer. Accessed May 2026.
3. National Cancer Institute. Melanoma Treatment (PDQ®)–Health Professional Version. Accessed May 2026.
4. World Health Organization. Ultraviolet radiation and the INTERSUN Programme. Accessed May 2026.
5. Cleveland Clinic. How to Spot a Melanoma. Accessed May 2026.

```